✦ LIBER ✦

PND32 Cost-Utility Analysis of Ropinirole in Parkinson'S Disease (PD) Treatment

✍ Scribed by I. Zerda; A. Drozdz; D. Brzyski; M. Pochopien; B. Gwiosda; B. Lisiecka; D. Barlog; C. Glogowski; D. Dziurda; P. Rys; R Plisko

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND20 IS ROPINIROLE-PROLONGED RELEASE A

✍ A Novak; M Boomsma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PND24 TREATMENT OF ADVANCED PARKINSON'S

✍ ML Tarrants; H Groenendaal; C Armand 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PND28 COST-UTILITY ANALYSIS OF ROTIGOTIN

✍ H Benhaddi; A Gunn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PND70 Patient Characteristics and Treatm

✍ Grubb, E.; Castelli-Haley, J.; Treglia, M.; Lage, M.J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND21 COST-UTILITY OF PRAMIPEXOL COMPARE

✍ J Idrovo; R Rivas; L Zapata 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PND39 Cost-Utility Analysis of a Therape

✍ Costa, N.; Derumeaux-Burel, H.; Canivet, C.; Ory, F.; Brefel-Courbon, C.; Molini 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB